In fairness, it's an estimate. They can't control every aspect of the entire maze they're navigating. The complexity of that maze has increased tenfold both inside and outside the company because we are in the midst of a pandemic! And we are not a only a biotech company, but a biotech company suddenly and unexpectedly working on the pandemic. Despite their history of being a little slow, I think they deserve some slack and understanding in this exceptional time.
MSB Trading - 2020, page-21292
-
- There are more pages in this discussion • 1,869 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
-0.050(4.39%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.17 | $1.07 | $8.385M | 7.489M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8500 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 26954 | 3 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |